Skip to main content
. 2021 Sep 2;28(38):52798–52809. doi: 10.1007/s11356-021-16104-6

Table 3.

Marine-derived sulfated polysaccharides having inhibitory properties against SAR-CoV-2

Compound name Mechanism of action References
Iota-carrageenan derived nasal spray In-vitro inhibition of COVID-19 Bansal et al. 2020
Carrageenan-derived nasal spray 2.5% decrease in recurring symptoms Koenighofer et al. 2014
Carrageenan and fucoidan Binds with s-glycoprotein of virus Song et al. 2020
Iota-carrageenan derived lozenges S-glycoprotein denaturation Morokutti-Kurz et al. 2017
Iota-carrageenan and fucoidan kappa carrageenan Prevention of respiratory tract infections Grassauer et al. 2008
Iota-carrageenan-derived nasal spray Upper respiratory tract nasal congestion Graf et al. 2018
Iota-carrageenan The increased recovery rate from COVID-19 infection by 2.4-fold Hemilia et al., 2020
Lambda-carrageenan Prevents viral attachment to receptors of cell surface Jang et al. 2020
Fucoidan Binding of sulfated polysaccharides with s-glycoprotein Kwon et al. 2020